Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Orient Technologies (NSE: ORIENTTECH) Q3 FY26 results: Why short-term margin pain may be the price of securing long-cycle government and services revenue
Read More 5 minute read General business news Houlihan Lokey’s Sandro Galfetti hire: What it means for private equity secondaries Houlihan Lokey adds Sandro Galfetti to lead its GP-led secondary advisory practice in Europe. Find out how this hire deepens its private capital capabilities. byPallavi MadhirajuSeptember 1, 2025